These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 15897565)
1. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Berchuck A; Iversen ES; Lancaster JM; Pittman J; Luo J; Lee P; Murphy S; Dressman HK; Febbo PG; West M; Nevins JR; Marks JR Clin Cancer Res; 2005 May; 11(10):3686-96. PubMed ID: 15897565 [TBL] [Abstract][Full Text] [Related]
2. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Berchuck A; Iversen ES; Lancaster JM; Dressman HK; West M; Nevins JR; Marks JR Am J Obstet Gynecol; 2004 Apr; 190(4):910-25. PubMed ID: 15118612 [TBL] [Abstract][Full Text] [Related]
3. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study. Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688 [TBL] [Abstract][Full Text] [Related]
4. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma. Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504 [TBL] [Abstract][Full Text] [Related]
5. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184 [TBL] [Abstract][Full Text] [Related]
6. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038 [TBL] [Abstract][Full Text] [Related]
7. Screening for genes associated with ovarian cancer prognosis. Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465 [TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells. Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948 [TBL] [Abstract][Full Text] [Related]
14. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings. Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616 [TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype. Barnett JC; Bean SM; Whitaker RS; Kondoh E; Baba T; Fujii S; Marks JR; Dressman HK; Murphy SK; Berchuck A Gynecol Oncol; 2010 Mar; 116(3):556-62. PubMed ID: 20006900 [TBL] [Abstract][Full Text] [Related]
16. Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study. Marko NF; Toms SA; Barnett GH; Weil R Genomics; 2008 May; 91(5):395-406. PubMed ID: 18343632 [TBL] [Abstract][Full Text] [Related]
17. Analysis of gene expression in early-stage ovarian cancer. Marchini S; Mariani P; Chiorino G; Marrazzo E; Bonomi R; Fruscio R; Clivio L; Garbi A; Torri V; Cinquini M; Dell'Anna T; Apolone G; Broggini M; D'Incalci M Clin Cancer Res; 2008 Dec; 14(23):7850-60. PubMed ID: 19047114 [TBL] [Abstract][Full Text] [Related]
18. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910 [TBL] [Abstract][Full Text] [Related]
19. High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. Yoshihara K; Tsunoda T; Shigemizu D; Fujiwara H; Hatae M; Fujiwara H; Masuzaki H; Katabuchi H; Kawakami Y; Okamoto A; Nogawa T; Matsumura N; Udagawa Y; Saito T; Itamochi H; Takano M; Miyagi E; Sudo T; Ushijima K; Iwase H; Seki H; Terao Y; Enomoto T; Mikami M; Akazawa K; Tsuda H; Moriya T; Tajima A; Inoue I; Tanaka K; Clin Cancer Res; 2012 Mar; 18(5):1374-85. PubMed ID: 22241791 [TBL] [Abstract][Full Text] [Related]
20. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Schwartz DR; Kardia SL; Shedden KA; Kuick R; Michailidis G; Taylor JM; Misek DE; Wu R; Zhai Y; Darrah DM; Reed H; Ellenson LH; Giordano TJ; Fearon ER; Hanash SM; Cho KR Cancer Res; 2002 Aug; 62(16):4722-9. PubMed ID: 12183431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]